EUCURE BIOPHARMA
Eucure Biopharma is a global biotechnology company headquartered in Beijing, China. They are committed to the discovery and development of innovative immuno-oncology targeted antibodies which mainly focus on immune checkpoints. Several products have entered the CMC stage and has applied for clinical trial in 2019. Their mission is to develop antibody treatments to improve the survival rate of tumor patients.
EUCURE BIOPHARMA
Industry:
Biotechnology Health Care Health Diagnostics Pharmaceutical
Founded:
2016-11-01
Address:
Beijing, Beijing, China
Country:
China
Website Url:
http://www.eucure.com
Total Employee:
11+
Status:
Active
Contact:
86-10-5631-5309
Email Addresses:
[email protected]
Total Funding:
250 M CNY
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Domain Not Resolving Mobile Non Scaleable Content Nginx Euro Microsoft Exchange Online Office 365 Mail
Similar Organizations
Aura Biosciences
Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.
Day One Biopharmaceuticals
Day One Biopharmaceuticals is a biotechnology company that focuses on developing new cancer therapies for patients of all ages.
Vor Biopharma
Vor Biopharma is an immuno-oncology company that develops therapies for treating cancer.
Current Employees Featured
Founder
Investors List
3E Bioventures
3E Bioventures investment in Series B - Eucure Biopharma
CMB International Capital Corporation
CMB International Capital Corporation investment in Series B - Eucure Biopharma
SDIC Venture Capital
SDIC Venture Capital investment in Series A - Eucure Biopharma
BVCF
BVCF investment in Series A - Eucure Biopharma
BVCF
BVCF investment in Series A - Eucure Biopharma
SDIC Venture Capital
SDIC Venture Capital investment in Series A - Eucure Biopharma
More informations about "Eucure Biopharma" on Search Engine
About Eucure - Eucure - Eucure
Eucure Biopharma, a wholly-owned subsidiary of Biocytogen, focuses on clinical development. Eucure Biopharma is a China based innovative biotechnology company with global avision specializing in developing innovative antibody drugs with independent intellectual property rights.See details»
Eucure - Eucure
About Eucure. Eucure Biopharma is a China based innovative biotechnology company with global vision, specializing in developing innovative antibody drugs with independent intellectual property rights. Eucure Biopharma owns a seasoned team with in-depth experience in global clinical development, and is dedicated to providing a comprehensive ...See details»
Eucure Biopharma - Crunchbase Company Profile & Funding
Company Type For Profit. Contact Email [email protected]. Phone Number 86-10-5631-5309. Eucure Biopharma is a global biotechnology company headquartered in Beijing, China. They are committed to the discovery and development of innovative immuno-oncology targeted antibodies which mainly focus on immune checkpoints.See details»
Eucure Biopharma, a Subsidiary of Biocytogen, and TRACON ...
Eucure Biopharma, a subsidiary of Biocytogen, is a China based innovative biotechnology company with global vision, specializing in developing innovative antibody drugs with independent intellectual property rights.See details»
Eucure Biopharma, a Subsidiary of Biocytogen Pharmaceuticals, …
As a wholly owned subsidiary of Biocytogen, Eucure Biopharma focuses on antibody drug therapy for oncology and other indications. Relying on a strong clinical development team with extensive experience, Eucure Biopharma develops innovative drugs to meet clinical needs for patients worldwide.See details»
Biocytogen Announces the Merger of Eucure Biopharma to …
Biocytogen announced the merger of an innovative biopharmaceutical development enterprise of the clinical phase, Eucure Biopharma, which will continue to operate as a wholly owned subsidiary of Biocytogen. As the merger, Biocytogen also completed the transformation from CRO to Biotech.See details»
News - Eucure - Eucure
Eucure Biopharma is a China based innovative biotechnology company with global avision specializing in developing innovative antibody drugs with independent intellectual property rights.See details»
Biocytogen/Eucure Biopharma's CTLA-4 and CD40 mAbs …
Jul 6, 2021 Eucure Biopharma is a wholly owned subsidiary of Biocytogen, a biotechnology company focused on therapeutic antibody discovery, antibody & biologic efficacy testing, and genetic engineering for...See details»
Eucure Biopharma Announces Breakthrough Phase I Results for …
BOSTON and BEIJING, March 22, 2021 /PRNewswire/ -- Eucure Biopharma, a subsidiary of Biocytogen focused on developing proprietary immuno-oncology antibodies, announced that its anti-CTLA-4...See details»
Pipeline - Eucure - Eucure
Eucure Biopharma is a China based innovative biotechnology company with global avision specializing in developing innovative antibody drugs with independent intellectual property rights.See details»
Biocytogen Subsidiary, Eucure Biopharma, Announces the First …
Mar 8, 2022 As a wholly owned subsidiary of Biocytogen, Eucure Biopharma is responsible for clinical development of Biocytogen's R&D pipelines, focusing on antibody drug therapy for oncology and other...See details»
Biocytogen/Eucure Biopharma to Present Clinical Data from
BEIJING, May 24, 2022 /CNW/ -- Eucure Biopharma, a wholly owned subsidiary of Biocytogen Pharmaceuticals ( Beijing) Co., Ltd. ("Biocytogen"), today announced that it will present two...See details»
Biocytogen/Eucure Biopharma Announce the Completion of First …
BEIJING, Dec. 9, 2021 /CNW/ -- Eucure Biopharma, a wholly owned subsidiary of Biocytogen, announced the first patient dosing for a phase I clinical trial of YH004 (anti-4-1BB monoclonal...See details»
Eucure Biopharma, a Subsidiary of Biocytogen ... - Business Wire
Oct 18, 2022 As a wholly owned subsidiary of Biocytogen, Eucure Biopharma focuses on antibody drug therapy for oncology and other indications. Relying on a strong clinical development team with extensive...See details»
Eucure Biopharma, a Subsidiary of Biocytogen, Announces …
Nov 1, 2022 As a wholly owned subsidiary of Biocytogen, Eucure Biopharma focuses on antibody drug therapy for oncology and other indications. Relying on a strong clinical development team with extensive...See details»
Eucure Biopharma - Funding, Financials, Valuation & Investors
Eucure Biopharma has raised a total of. CN¥250M. in funding over 3 rounds. Their latest funding was raised on Mar 28, 2018 from a Series B round. Eucure Biopharma is funded by 4 investors. 3E Bioventures and CMB International Capital Corporation are the most recent investors. Unlock for free.See details»
Co-Founder and President @ Eucure Biopharma - Crunchbase
Jian Ni. Summary. Overview. Number of Founded Organizations 1. CB Rank (Person) 855,255. Primary Job Title Co-Founder and President. Primary Organization. Eucure Biopharma. Location Beijing, Beijing, China. Regions Asia-Pacific (APAC) Gender Female. Also Known As 倪健, Ni Jian.See details»
Biocytogen Subsidiary Eucure Biopharma Completes First
Apr 6, 2022 As a wholly owned subsidiary of Biocytogen, Eucure Biopharma undertakes the mission of clinical development for Biocytogen's R&D pipelines. Relying on a strong clinical development team and...See details»
Syncromune, Inc. Enters into an Exclusive Worldwide License …
Oct 18, 2022 As a wholly owned subsidiary of Biocytogen, Eucure Biopharma focuses on antibody drug therapy for oncology and other indications. Relying on a strong clinical development team with extensive experience, Eucure Biopharma develops innovative drugs to meet clinical needs for patients worldwide.See details»
Eucure Biopharma - Crunchbase
Organization. Eucure Biopharma. Connect to CRM. Summary Financials People Technology Signals & News Similar Companies. Similar Companies. Powered by AI. Eucure Biopharma, Halo Labs, Vor Biopharma, NephroDI Therapeutics, Navrogen, and Pinpoint Therapeutics are all part of the biotechnology and immuno-oncology sector.See details»